Extended-duration low-molecular-weight heparin prophylaxis following total joint arthroplasty.

American journal of orthopedics (Belle Mead, N.J.)

Volumn 31, Issue 9 Suppl, 2002, Pages 31-36

  Whang, Peter G ^a   Lieberman, Jay R ^a  

^a UCLA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; LOW MOLECULAR WEIGHT HEPARIN;

CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; HEALTH CARE COST; HIP ARTHROPLASTY; HUMAN; KNEE ARTHROPLASTY; POSTOPERATIVE COMPLICATION; RANDOMIZED CONTROLLED TRIAL; REVIEW; RISK FACTOR; VEIN THROMBOSIS;

ANTICOAGULANTS; ARTHROPLASTY, REPLACEMENT, HIP; ARTHROPLASTY, REPLACEMENT, KNEE; HEALTH CARE COSTS; HEPARIN, LOW-MOLECULAR-WEIGHT; HUMANS; POSTOPERATIVE COMPLICATIONS; RANDOMIZED CONTROLLED TRIALS; RISK FACTORS; VENOUS THROMBOSIS;

EID: 0036726678     PISSN: 10784519     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (30)